Hereditary Haemochromatosis: Recent Advances in Biology and Management

References

• Sheldon, J. H. (1935). Haemochromatosis. London, Oxford University Press.
   Google Scholar
• MacDonald, R. A. (1964). Hemochromatosis and hemosiderosis. Springfield, III., Charles C Thomas.
   Google Scholar
• Simon, M., Bourel, M., Fauchet, R. and Genetet, B. (1976). Association of HLA A3 and HLA B14 antigens with idiopathic haemochromatosis. Gut, 17,332–334.
   PubMed Web of Science ®Google Scholar
• Simon, M., Le Mignon, L., Fauchet, R., et al., (1987). A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of gene near the HLA-A locus and characters to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am. J. Hum. Genet., 41, 89–105.
   PubMed Web of Science ®Google Scholar
• Simon, M., Alexandre, J. L., Fauchet, R., Genetet, B. and Bourel, M. (1980). The genetics of haemochromatosis. Prog. Med. Genet., 4, 135–168.
   PubMedGoogle Scholar
• Feder, J. N., Gnirke, A., Thomas, W., et al., (1996). A novel MHC Class 1-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet., 13, 399–408.
   PubMed Web of Science ®Google Scholar
• Merryweather Clarke, A. T., Liu, Y. T., Shearman, J. D., Pointon, J. J. and Robson, K. J. (1997). A rapid non-invasive method for the detection of the haemochromatosis C282Y mutation. Br. J. Haematol., 99, 460–463.
   PubMed Web of Science ®Google Scholar
• Bothwell, T. H., Charlton, R. W. and Motulsky, A. G. (1995). Hemochromatosis. In “The Metabolic and Molecular Bases of Inherited Disease“, edited by, C. R. Scriver, A. L. Beaudet, W. S. Sly and D. Valle, New York, McGraw-Hill Inc, pp. 2237–2269.
   Google Scholar
• Moirand, R., Adams, P. C., Bicheler, V., Brissot, P. and Deugnier, Y. (1997). Clinical features of genetic hemochromatosis in women compared with men. Ann. Intern. Med., 127, 105–110.
   PubMed Web of Science ®Google Scholar
• Fillet, G., Beguin, Y. and Baldelli, L. (1989). Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood, 74(2), 844–851.
   PubMed Web of Science ®Google Scholar
• Moura, E., Noordermeer, M. A., Verhoeven, N., Verheul, A. F. and Marx, J. J. (1998). Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood, 92, 2511–2519.
   PubMed Web of Science ®Google Scholar
• Bassett, M. L., Halliday, J. W., Ferris, R. A. and Powell, L. W. (1984). Diagnosis of hemochromatosis in young subjects: predictive accuracy of serum iron, transferrin saturation and serum ferritin. Gastroenterology, 87, 628–634.
   PubMed Web of Science ®Google Scholar
• Valberg, L. S., Simon, J. B., Manley, P. N., Corbett, W. E. and Ludwig, J. (1975). Distribution of storage iron as body iron stores expand in patients with hemochromatosis. J. Lab. Clin. Med., 86, 479–489.
   PubMed Web of Science ®Google Scholar
• Beutler, E., Gelbart, T., West, C., et al., Mutation analysis in hereditary hemochromatosis. Blood Cells Mol. Dis., 22, 187–194.
   PubMed Web of Science ®Google Scholar
• Jazwinska, E. C., MacCullen, L., Busfield, F., et al., (1996). Haemochromatosis and HLA-H. Nat. Genet., 14, 251–252.
   PubMed Web of Science ®Google Scholar
• Jezequel, P., Bargain, M., Lellouche, F., Geffroy, F. and Dorval, I. (1998). Allele frequencies of hereditary hemochromatosis; gene mutations in a local population of west Brittany. Hum. Genet., 102, 332–333.
   PubMed Web of Science ®Google Scholar
• Willis, G., Jennings, B. A., Goodman, E., Fellows, I. and Wimperis, J. Z. (1997). A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in Eastern England. Blood Cells Mol. Dis., 23, 288–291.
   PubMed Web of Science ®Google Scholar
• Carella, M., D'Ambrosio, L., Totaro, A., et al., (1997). Mutational analysis of the HLA-H gene in Italian hemochromatosis patients. Am. J. Hum. Genetics, 60, 828–832.
   PubMed Web of Science ®Google Scholar
• Beutler, E. and Gelbart, T. (1997). HLA-H mutations in the Ashkenazi-Jewish population. Blood Cells Mol. Dis., 23, 95–98.
   PubMed Web of Science ®Google Scholar
• Roth, M., Giraldo, P., Hariti, G., et al., (1997). Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics, 46, 222–225.
   PubMed Web of Science ®Google Scholar
• Cullen, L. M., Gao, X., Easteal, S. and Jazwinska, E. C. (1998). The hemochromatosis 845 G→A and 187 C→G mutations: prevalence in non-Caucasian populations. Amer. J. Hum. Genet., 62, 1403–1407.
   PubMed Web of Science ®Google Scholar
• Barton, J. C., Shih, W. W. H., Sawada-Hirai, R., et al., (1997). Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatability complex are responsible for hemochromatosis. Blood Cells Mol. Dis., 23, 135–145.
   PubMed Web of Science ®Google Scholar
• Rhodes, D. A., Raha Choudury, R., Cox, T. M. and Trowsdale, J. (1997). Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis. J. Med. Genet., 34, 761–764.
   PubMed Web of Science ®Google Scholar
• Crawford, D. H. G., Halliday, J. W., Summers, K. M., Burke, M. and Powell, L. W. (1993). Concordance of iron storage in siblings with genetic hemochromatosis: Evidence for a predominantly genetic effect on iron storage. Hepatology, 17, 833–837.
   PubMed Web of Science ®Google Scholar
• Merryweather Clarke, A. T., Worwood, M., Parkinson, L., et al., (1998). The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Brit. J. Haematol., 101, 369–373.
   PubMed Web of Science ®Google Scholar
• Willis, G., Wimperis, J. Z., Lonsdale, R., Sampson, M. J. and Jennings, B. A. (1998). Low penetrance of HFE mutation in an English population. Blood, 92(1), 324A.
   Google Scholar
• Olynyk, J., Cullen, D., Rossi, R., et al., (1998). Clinical expression of the hemochromatosis genotype Cys282Tyr in the Busselton population. Hepatology, 28, 528A.
   Web of Science ®Google Scholar
• Leggett, B. A., Brown, N. N., Bryant, S. J., et al., (1990). Factors affecting the concentration of serum ferritin in a healthy Australian population. Clin. Chem., 36, 1350–1355.
   PubMed Web of Science ®Google Scholar
• Powell, L. W., Jazwinska, E. and Halliday, J. W. (1994). Primary iron overload. In “Iron Metabolism in Health and Disease”, edited by J. H. Brock, J. W. Halliday, M. J. Pippard and L. W. Powell, London, Saunders, pp 228–270.
   Google Scholar
• Crawford, D. H., Jazwinska, E. C., Cullen, L. M. and Powell, L. W. (1998). Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology, 114, 1003–1008.
   PubMed Web of Science ®Google Scholar
• Pietrangelo, A. and Camaschella, C. (1998). Molecular genetics and control of iron metabolism in hemochromatosis. Haematologica, 83, 456–461.
   PubMed Web of Science ®Google Scholar
• Feder, J.N., Penny, D. M., Irrinki, A., et al., (1998). The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. U.S.A., 95, 1473–1477.
   Web of Science ®Google Scholar
• Gross, C. N., Irrinki, A., Feder, J. N. and Enns, C. A. (1998). Co-trafficking of HFE, a non-classical major histocompatibility complex class 1 protein, with the transferrin receptor implies a role in intracellular iron regulation. J. Biol. Chem., 273, 22068–22074.
   PubMed Web of Science ®Google Scholar
• Feder, J. N., Tsuchihashi, Z., Irrinki, A., et al., (1997). The hemochromatosis founder mutation in HLA-A disrupts beta 2-microglobulin interaction and cell surface expression. J. Biol. Chem., 272, 14025–14028.
   PubMed Web of Science ®Google Scholar
• Cairo, G., Recalcati, S., Montosi, G., et al., (1997). Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood, 89, 2546–2553.
   PubMed Web of Science ®Google Scholar
• Shaheen, N. J., Bacon, B. R. and Grimm, I. S. (1998). Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation. Hepatology, 28, 526–529.
   PubMed Web of Science ®Google Scholar
• Bacon, B. R. and Sadiq, S. A. (1997). Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am. J. Gastroenterol., 92, 784–789.
   PubMed Web of Science ®Google Scholar
• Niederau, C., Fischer, R., Purschel, A., et al., (1996). Longterm survival in patients with hereditary hemochromatosis. Gastroenterology, 110, 1107–1119.
   PubMed Web of Science ®Google Scholar
• Powell, L. W., Summers, K. W., Board, P. G., et al., (1990). Expression of hemochromatosis in homozygous subjects: implications for early diagnosis and prevention. Gastroenterology, 98, 1625–1632.
   PubMed Web of Science ®Google Scholar
• Adams, P. C. and Valberg, L. S. (1996). Evolving expression of hereditary hemochromatosis. Semin. Liver. Dis., 16, 47–54.
   PubMed Web of Science ®Google Scholar
• Niederau, C., Strohmeyer, G. and Stremmel, W. (1994). Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv. Exp. Biol. Med., 356, 303–308.
   PubMedGoogle Scholar
• Sinigaglia, L., Fargion, S., Fracanzani, A. L., et al., (1997). Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J. Rheumatol., 24, 1809–1813.
   PubMed Web of Science ®Google Scholar
• Chevrant-Breton, J., Simon, M., Bourel, M. and Ferrand, B. (1977). Cutaneous manifestations of idiopathic hemochromatosis. Arch. Dermatol., 113, 161–165.
   PubMedGoogle Scholar
• Iancu, T. C., Deugnier, Y., Halliday, J. W., Powell, L. W. and Brissot, P. (1997). Ultrastructural sequences during iron overload in genetic hemochromatosis. J. Hepatol., 27, 628–638.
   PubMed Web of Science ®Google Scholar
• Hsing, A. W., McLaughlin, J. K., Olsen, J. H., et al., (1995). Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark, Int. J. Cancer, 60, 160–162.
   PubMed Web of Science ®Google Scholar
• Hramiak, I. M., Finegood, D. T. and Adams, P. C. (1997). Factors affecting glucose tolerance in hereditary hemochromatosis. Clin. Invest. Med., 20, 110–118.
   PubMed Web of Science ®Google Scholar
• Bezwoda, W. R., Bothwell, T. H., van der Walt, L. A., Kronhein, S. and Pimstone, N. L. (1977). An investigation into gonadal dysfunction in patients with idiopathic haemochromatosis. Clin. Endocrinol., 6, 377–385.
   PubMed Web of Science ®Google Scholar
• Siminosky, K., D'Costa, M. and Walfish, P. G. (1990). Hypogonadotrophic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement. J. Endocrinol. Invest., 13, 849–854.
   PubMed Web of Science ®Google Scholar
• Bonkovsky, H. L., Fitzpatrick, M., Pimstone, N., et al., (1998). Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology, 27, 1661–1669.
   PubMed Web of Science ®Google Scholar
• Roberts, A. G., Whatley, S. D., Morgan, R., et al., (1997). Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet, 349, 321–323.
   PubMed Web of Science ®Google Scholar
• Stuart, K. A., Busfield, F., Jazwinska, E.C., et al., (1998). The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J. Hepatol., 28, 404–409.
   PubMed Web of Science ®Google Scholar
• George, K. D., Goldwurm, S., MacDonald, G. A., et al., (1998). Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology, 114, 311–318.
   PubMed Web of Science ®Google Scholar
• Piperno, A., Vergani, A., Malosio, I., et al., (1998). Hepatic iron concentrations in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology, 28, 1105–1109.
   PubMed Web of Science ®Google Scholar
• Smith, B. C., Gorve, J., Guzail, M. A., et al., (1998). Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology, 27, 1695–1699.
   PubMed Web of Science ®Google Scholar
• Witte, D. L., Crosby, W. H., Edwards, C. Q., Fairbanks, V. F. and Mitros, F. A. (1996). Hereditary hemochromatosis. Clin. Chim. Acta, 245, 139–200.
   PubMed Web of Science ®Google Scholar
• McLaren, C. E., McLachlan, G., Halliday, J. W., et al., (1998). Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology, 114, 543–549.
   PubMed Web of Science ®Google Scholar
• Adams, P. C. and Chakrabarti, S. (1998). Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology, 114, 319–323.
   PubMed Web of Science ®Google Scholar
• Bothwell, T. H., Abrahams, C., Bradlow, B. A. and Charlton, R. W. (1969). Idiopathic and Bantu hemochromatosis: a comparative histological study. Arch. Path., 79, 163–168.
   Google Scholar
• Torrance, J. D. and Bothwell, T. H. (1980). Tissue iron stores. In “Methods in Hematology“, edited by J. D. Cook, New York, Churchill Livingstone, p 9.
   Google Scholar
• George, P. M., Conaghan, C., Angus, H. B., Walmsley, T. A. and Chapman, B. A. (1996). Comparison of histological and biochemical hepatic iron indexes in the diagnosis of genetic hemochromatosis. J. Clin. Path., 49, 159–163.
   PubMed Web of Science ®Google Scholar
• Bassett, M., Halliday, J. W. and Powell, L. W. (1986). Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology, 6, 24–29.
   PubMed Web of Science ®Google Scholar
• Adams, P. C., Bradley, C. and Henderson, A. R. (1997). Evaluation of the hepatic iron index as a diagnostic criterion for genetic hemochromatosis. J. Lab. Clin. Med., 130, 509–514
   PubMed Web of Science ®Google Scholar
• Sallie, R. W., Reed, W. D. and Shilkin, K. B. (1991). Confirmation of the efficacy of the hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut, 32, 207–210.
   PubMedGoogle Scholar
• Powell, L. W. and Jazwinska, E. C. (1996). Hemochromatosis in heterozygotes. N. Eng. J. Med., 335, 1837–1839.
   PubMed Web of Science ®Google Scholar
• Camaschella, C., Roetto, A., Cicilano, M., et al., (1997). Juvenile and adult hemochromatosis are distinct genetic disorders. Eur. J. Hum. Genet., 5, 371–375.
   PubMed Web of Science ®Google Scholar
• Kelly, A. L., Rhodes, D. A., Roland, J. M., Schofield, P. and Cox, T. M. (1998). Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease. Quart. J. Med., 91, 607–618.
   Google Scholar
• Friedman, B. M., Baynes, R. D., Bothwell, T. H., et al., (1990). Dietary iron overload in southern African rural blacks. S. Afr. Med. J., 78, 301–305.
   PubMed Web of Science ®Google Scholar
• Moyo, V. M., Mandishona, E., Hasstedt, S. J., et al., (1998). Evidence of genetic transmission in African iron overload. Blood, 91, 1–9.
   PubMed Web of Science ®Google Scholar
• Barton, J. C., Edwards, C. Q., Bertoli, L. F., Shroyer, T. W. and Hudson, S. L. (1995). Iron overload in African Americans. Am. J. Med., 99, 616–623.
   PubMed Web of Science ®Google Scholar
• Wurapa, R. K., Gordeuk, V. R., Brittenham, G. R., et al., (1996). Primary iron overload in African Americans. Am. J. Med., 101, 9–18.
   PubMed Web of Science ®Google Scholar
• Propper, R. D., Cooper, B., Rufo, R. R., et al., (1977). Continuous subcutaneous administration of deferoxamine in patients with iron overload. N. Eng. J. Med., 297, 418–423.
   PubMed Web of Science ®Google Scholar
• Balan, V., Baldus, W., Fairbanks, V., et al., (1994). Screening for hemochromatosis: A cost-effectiveness study based on 12,258 patients. Gastroenterology, 107, 453–459.
   PubMed Web of Science ®Google Scholar
• Buffone, G. J. and Beck, J. R. (1994). Cost-effectiveness analysis for evaluation of screening programs: Hereditary hemochromatosis. Clin. Ghent., 40, 1631–1636.
   Google Scholar
• Phatak, P. D., Guzman, G., Woll, J., Robeson, A. and Phelps, C. E. (1994). Cost-effectiveness of screening for hemochromatosis. Arch. Int. Med., 154, 769–776.
   PubMedGoogle Scholar
• Bassett, M. L., Halliday, J. W., Bryant, S., Dent, O. and Powell, L. W. (1988). Screening for hemochromatosis. Ann. N. Y. Acad. Sci., 526, 274–289.
   PubMed Web of Science ®Google Scholar
• Edwards, C. Q., Griffen, L. M., Goldgar, D., et al., (1988). Prevalence of hemochromatosis among 11065 presumably healthy blood donors. N. Eng. J. Med., 318, 1355–1362.
   PubMed Web of Science ®Google Scholar
• Meyer, T., Baynes, R., Bothwell, T., et al., (1990). Phenotypic expression of the HLA linked iron-loading gene in males over the age of 40 years: A population study using serial ferritin estimations. J. Intern. Med., 227, 397–406.
   PubMed Web of Science ®Google Scholar
• Niederau, C., Niederau, C. M., Lange, S., et al., (1998). Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann. Intern. Med., 128, 337–345.
   PubMed Web of Science ®Google Scholar
• Bassett, M. L., Leggett, B. A., Halliday, J. W., Webb, S. and Powell, L. W. (1997). Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. J. Hepatol., 27, 517–524.
   PubMed Web of Science ®Google Scholar
• Burke, W., Thomson, E., Khoury, M. J., et al., (1998). Hereditary hemochromatosis: gene discovery and its implications for population-based screening. J. Amer. Med. Ass., 280, 172–178.
   PubMed Web of Science ®Google Scholar
• Gambino, R. (1990). Routine screening for iron status. Hospital Practice, 26(3), 41–44.
   Google Scholar